Copyright © 2016

Aridis Pharmaceuticals, Inc.

5941 Optical Court, San Jose, CA 95138

Phone: 408-385-1742

Site Map

Privacy Policy

Financial Conflict of Interest Policy

Back to top

Previous page

Products

Product Overview

Hospital-acquired Infections

Cystic Fibrosis

AR-101 Anti-P.aeruginosa LPS mAb

P.aeruginosa & Pneumonia

AR-101 Clinical Data

AR-201 Anti-RSV mAb

AR-301 Anti-S.aureus mAb

AR-401Anti-A.baumannii mAb

Aerucin Anti-P.aeruginosa mAb

Hospital-acquired Infections

Cystic Fibrosis

P.aeruginosa & Pneumonia

Panaecin (Gallium Citrate)

Cystic Fibrosis

COPD

About

About Aridis

Executive Team

Scientific Advisory Board

Clinical Advisory Board

Technologies

Technology Overview

MabIgX® Technology

News

News

Collaborations

Contact

Contact Us

Pages Accessible from Links in the Header and Footer:

Site Search

Site Map (this page)

Privacy Policy

Financial Conflict of Interest Policy


Site Map

PHARMACEUTICALS

Breakthrough Therapies for

Antibiotic Resistant Infections

Aridis